Seeking Alpha
10 Jul 2026, 15:50 UTC · 1h ago
Viking Therapeutics: Still Cheap, But Watch Double Top
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Seeking Alpha
10 Jul 2026, 15:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Viking Therapeutics is advancing its GLP-1 weight-loss pipeline with Phase 3 trials progressing and oral formulation development accelerating. — Progress toward Phase 3 and oral versions is a critical value inflection point for biotech firms in the high-demand weight-loss market.
+0.60Consensus analyst price targets for VKTX average $92.58, indicating significant potential upside from current levels. — Strong analyst sentiment and price target gaps often act as a catalyst for buying pressure if the market aligns with these targets.
+0.40The GLP-1 market is projected to reach $190 billion by 2035, with VKTX positioned to capture a portion of this expansion. — A massive total addressable market (TAM) increases the long-term valuation ceiling and attractiveness for potential M&A.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The article highlights strong pipeline progress in GLP-1 weight-loss, substantial price target upside, and an attractive valuation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
2h ago
